CLINICAL AND PARACLINICAL CHARACTERISTICS OF PATIENTS WITH SPUTUM SMEAR-NEGATIVE PULMONARY TUBERCULOSIS DIAGNOSED BY XPERT MTB/ RIF ASSAY ON BRONCHOALVEOLAR LAVAGE FLUID OBTAINED VIA BRONCHOSCOPY AT THAI NGUYEN NATIONAL HOSPITAL

Downloads

Download data is not yet available.
PDF (Tiếng Việt) | 0 | 0

Abstract

Objective: To determine the rate and clinical and imaging characteristics in patients with AFB (-) pulmonary tuberculosis diagnosed using chest computed tomography (CT) and the GeneXpert MTB test in the Respiratory Department of Thai Nguyen National Hospital in 2023 - 2024. Methods: Description, cross-sectional research design, purposeful sample selection; Select all research objects. Research period 1/2023 to 11/2024. Results: The proportion of patients with suspected AFB pulmonary tuberculosis (-) determined by Genexpert MTB (+) through bronchoalveolar lavage fluid accounted for 73/82 study subjects, of which 73 patients with AFB pulmonary tuberculosis (-) had highest age 73, lowest age 32; The most common age group is 50 - 59, with a very high proportion of men accounting for 87.6%. Clinical characteristics: dry cough in 9.6%; Cough with cloudy phlegm 82.1%; hemoptysis 8.3%. Thin body condition 35.6%, fever 21.9%. Lesion morphology: Heterogeneous opacities: 83.6%; consolidation: 6.8%; nodule 4.1%; millet: 4.1%; Tree-in-bud 5.5%; Bronchiectasis: 31.5%. Location of injury: Upper lobe: 42.5%; Lower lobe 9.6%; Diffuse multiple lobes: 47.9%. Duration of cough and sputum production < 2 weeks 16.4%; over 3 months 30.2%; Pleural tuberculosis: 26.4%; History of treatment for unspecified tuberculosis lung disease within the previous 3 months accounts for a highrate of 35.6%; Patients with a history of alcoholism account for 46.5%; diabetes 5.4%. Conclusion: Genexpert MTB (+) through bronchoalveolar lavage fluid has diagnosed 36.8% of patients with suspected AFB (-) pulmonary tuberculosis, the proportion of male patients is higher than female, patients have similar clinical symptoms. tuberculosis is not high, fluctuating from 8.3% to 50.5% depending on the symptoms, the proportion of patients with atypical CT images of the lungs (single opacified nodule, Tree-in-bud) accounts for 9.6%, the location of the lesion is not high. atypical injury (lower lobe, diffuse) accounts for 57.5%, history related to the disease accounts for the highest rate, history of alcoholism accounts for 46.5%.

Published 2024-12-27
Fulltext
PDF (Tiếng Việt) | 0 | 0
Language
Issue Vol. 3 No. 4 (2024)
Section Original article
DOI
Keywords Lao phổi AFB (-), Genexpert MTB (+), Hình ảnh CT phổi AFB (-) pulmonary tuberculosis, Genexpert MTB (+), CT images of the lungs

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Journal of Science and Technology in Medicine and Pharmacy

1.
Pham, K. L., Duong, H. T., Chu, T. L., Pham, T. L. & Nguyen, K. L. CLINICAL AND PARACLINICAL CHARACTERISTICS OF PATIENTS WITH SPUTUM SMEAR-NEGATIVE PULMONARY TUBERCULOSIS DIAGNOSED BY XPERT MTB/ RIF ASSAY ON BRONCHOALVEOLAR LAVAGE FLUID OBTAINED VIA BRONCHOSCOPY AT THAI NGUYEN NATIONAL HOSPITAL. Tạp chí Khoa học và Công nghệ Y Dược 3, 131–143 (2024).

Đặng Thanh Phong, Võ Huỳnh Trang, Nguyễn Minh Phương. Nghiên cứu tình hình và yếu tố liên quan bệnh lao phổi AFB (-) tại trung tâm y tế huyện Tân Biên năm 2019. Tạp chí y dược học Cần Thơ 29, (2020).

Nguyễn Thị Minh Hạnh, Trần Thanh Hùng, Bùi Thị Cẩm Thùy. Nghiên cứu yếu tố dịch tễ, đặc điểm lâm sàng, cận lâm sàng của bệnh nhân lao phổi kháng rifampicin tại Bệnh viện lao và bệnh phổi Cần Thơ. Tạp chí y dược học Cần Thơ 72, (2024).

Phùng Anh Tuấn, Nguyễn Hồng Hải, Nguyễn Thái Quỳnh Anh. Đặc điểm hình ảnh tổn thương trên x-quang và cắt lớp vi tính của bệnh nhân lao phổi mới AFB dương tính. Tạp chí y dược học quân sự số đặc biệt, (2024).

Bộ Y tế. Hướng dẫn chẩn đoán, điều trị và dự phòng bệnh lao. Quyết định số 1314/QĐ-BYT. (2020).

Mavenyengwa, R. T., Shaduka, E., Maposa, I. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia. Infectious Diseases of Poverty 6(1), 13 (2017).

World Health Organization. Global Tuberculosis Report 2020. Geneva, Switzerland, (2020).